Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Scapular belt for the treatment of comminuted fractures of scapula].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2010
Same author

Manipulation of ordered nanostructures of protonated polyoxometalate through covalently bonded modification.

Chemistry (Weinheim an der Bergstrasse, Germany)·2010
Same author

Developments in nonsteroidal antiandrogens targeting the androgen receptor.

ChemMedChem·2010
Same author

Dynamic presentation of immobilized ligands regulated through biomolecular recognition.

Journal of the American Chemical Society·2010
Same author

[Research on crop-weed discrimination using a field imaging spectrometer].

Guang pu xue yu guang pu fen xi = Guang pu·2010
Same author

A palladium/copper bimetallic catalytic system: dramatic improvement for Suzuki-Miyaura-type direct C-H arylation of azoles with arylboronic acids.

Chemistry (Weinheim an der Bergstrasse, Germany)·2010

Related Experiment Videos

HDFT-MViT: a progressive core-enhanced mix framework for Alzheimer's disease classification using MRI images.

Dongyan Zhang1, Jincan Zhang1, Bo Liu1

  • 1College of Information Engineering, Henan University of Science and Technology, Luoyang, China.

Frontiers in Neurology
|July 3, 2026
PubMed
Summary

This study introduces HDFT-MViT, a novel deep learning model for Alzheimer's disease diagnosis using MRI scans. It achieves high accuracy with a lightweight design, making it suitable for clinical applications.

Keywords:
Alzheimer’s diseasedynamic filterlightweight transformermagnetic resonance imagingprogressive core-enhanced mixing

Related Experiment Videos

Area of Science:

  • Medical Imaging
  • Artificial Intelligence
  • Neuroscience

Background:

  • Accurate Alzheimer's disease (AD) diagnosis is crucial for timely intervention.
  • Current MRI-based methods using CNNs and ViTs have limitations in capturing both local and global features efficiently.
  • High computational complexity of ViTs hinders their use in resource-limited clinical settings.

Purpose of the Study:

  • To develop a lightweight hybrid deep learning model for enhanced Alzheimer's disease diagnosis from MRI scans.
  • To address the limitations of existing models in balancing local feature extraction and global dependency modeling.
  • To create an efficient and accurate tool for clinical AD diagnosis.

Main Methods:

  • Proposed HDFT-MViT, a hybrid architecture based on MobileViT, integrating hierarchical dynamic filters and lightweight Transformers.
  • Employed a progressive Core-Enhanced Mix design with MobileNetV2 for shallow layers and a dual-branch module for deeper layers.
  • Incorporated frequency-domain global modulation, spatial long-range dependency modeling, hierarchical fusion, and channel attention.

Main Results:

  • Achieved state-of-the-art classification accuracies of 98.85% (3-class) and 98.07% (4-class) on ADNI MRI datasets.
  • Maintained a lightweight profile with only 3.46 million parameters.
  • Demonstrated superior effectiveness and efficiency compared to existing methods.

Conclusions:

  • HDFT-MViT effectively balances local and global feature perception in a computationally efficient framework.
  • The model presents a promising tool for accurate and efficient clinical diagnosis of Alzheimer's disease.
  • The proposed architecture offers a viable solution for resource-constrained environments.